Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Biomarkers in Patients With Acute Myeloid Leukemia
This document reports on a completed clinical trial evaluating biomarkers in patients with acute myeloid leukemia.
-
CLINICAL_TRIALS research · 2015-04-30Clinical Trial Update: Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity
A completed clinical trial update on developing immunological assays to evaluate tumor antigen-specific immunity. The study includes ovarian…
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia [Phase 2]
A Phase 2 trial evaluating phenylbutyrate, dexamethasone, and sargramostim for refractory or relapsed acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML [Phase 2, Phase 3]
This clinical trial update discusses the use of granulocyte colony stimulating factor (G-CSF) after salvage chemotherapy in patients with re…
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia [Phase 1]
This Phase 1 trial update reports on the use of sorafenib in patients with refractory or relapsed acute leukemia, myelodysplastic syndromes,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-27Clinical Trial Update: Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell Transplant [Phase 1]
This Phase 1 trial investigates azacitidine after chemotherapy and donor lymphocyte infusion in patients with relapsed acute myeloid leukemi…
-
CLINICAL_TRIALS research · 2015-04-24Clinical Trial Update: A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q [Phase 2]
This is a Phase 2 clinical trial evaluating lenalidomide combined with escalating-dose chemotherapy for intermediate-2 or high-risk myelodys…
-
CLINICAL_TRIALS trial_result · 2015-04-22Clinical Trial Update: Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML [Phase 1]
Phase 1 trial evaluating allogeneic stem cell transplantation in high-risk CD33+ acute myeloid leukemia, myelodysplastic syndrome, and juven…
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia Patients
Clinical trial update comparing idarubicin to daunorubicin in acute myeloid leukemia reports higher induction remission rates and better res…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase [Phase 1]
This update summarizes a Phase 1 study of tipifarnib and bortezomib in patients with acute leukemia and blast-phase chronic myeloid leukemia…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Safety Study Evaluating Intravenous Infusions of Tigecycline to Treat Acute Myeloid Leukemia [Phase 1]
A Phase 1 safety study evaluating intravenous tigecycline for acute myeloid leukemia has completed.
-
CLINICAL_TRIALS withdrawal · 2015-04-13Clinical Trial Update: A Randomized Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects [Phase 2]
Phase 2 randomized pediatric acute myeloid leukemia trial evaluating decitabine epigenetic priming with frontline induction chemotherapy has…
-
CLINICAL_TRIALS withdrawal · 2015-04-10Clinical Trial Update: The Role of Maintenance Oral Clofarabine in Older Adults With Acute Myeloid Leukemia [Phase 1]
A Phase 1 trial evaluating maintenance oral clofarabine in older adults with Acute Myeloid Leukemia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants [Phase 2]
A Phase 2 clinical trial evaluating a sirolimus-tacrolimus combination following HLA-matched related peripheral blood stem cell transplantat…
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Dose-reduced Versus Standard Conditioning in MDS/sAML [Phase 3]
Phase 3 trial comparing dose-reduced versus standard conditioning in myelodysplastic syndromes and secondary acute myeloid leukemia was term…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not Suitable [Phase 2]
This document reports the results of a Phase 2 trial evaluating clofarabine in older patients with acute myeloid leukemia who are not suitab…
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia [Phase 2]
Phase 2 pilot trial evaluating erlotinib for de novo acute myeloid leukemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Investigation of Clofarabine in Acute Leukemias [Phase 2]
Phase 2 trial of clofarabine in acute myeloid leukemia, acute lymphoblastic leukemia, and chronic myelogenous leukemia has completed enrollm…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 1]
A Phase 1 study of combining Plerixafor with cytarabine and daunorubicin in adults with newly diagnosed acute myeloid leukemia has completed…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
A Phase 2 clinical trial update evaluating the combination of clofarabine and temsirolimus in older patients with relapsed or refractory acu…
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid Hemopathy [Phase 1, Phase 2]
An update on a Phase I/II trial evaluating an immune therapy given after allogeneic transplantation in patients with myeloid hematologic dis…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant [NA]
A completed clinical trial evaluated Thymoglobulin to prevent acute graft-versus-host disease in patients with acute myeloid leukemia or acu…
-
CLINICAL_TRIALS trial_result · 2015-03-12Clinical Trial Update: Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study of sirolimus in pediatric patients with relapsed or refractory acute leukemia or non-Hodgkin's lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Haploid Allogeneic Transplant Using the CliniMACS System [Phase 2]
A Phase 2 clinical trial evaluating haploid allogeneic transplantation using the CliniMACS System was terminated, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) [Phase 2]
Phase II clinical trial evaluating a combination of idarubicin, cytarabine, and vorinostat in high-risk myelodysplastic syndrome and acute m…